Axios @axios
Demand has soared in recent weeks for monoclonal antibodies to treat COVID. The treatment Trump received when he got COVID had a slow initial uptake, but is now gaining ground in the pandemic's fourth wave. https://t.co/b9SDxcApyD — PolitiTweet.org